Chris Nolet Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

Chris Nolet is Director of Revance Therapeutics, Inc.. Currently has a direct ownership of 43,606 shares of RVNC, which is worth approximately $112,067. The most recent transaction as insider was on May 01, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.6K
0% 3M change
52.44% 12M change
Total Value Held $112,067

Chris Nolet Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 25.59%
43,606 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
3,534 Added 11.0%
28,606 Common Stock
May 04 2022
BUY
Grant, award, or other acquisition
-
6,059 Added 19.46%
25,072 Common Stock
May 05 2021
BUY
Grant, award, or other acquisition
-
4,013 Added 17.43%
19,013 Common Stock

Also insider at

PTE
POLARITYTE, INC. Healthcare
Director
VIE
Viela Bio, Inc.
Director
JSPR
Jasper Therapeutics, Inc. Healthcare
Director
AVBP
ArriVent Biopharma, Inc.
Director
CN

Chris Nolet

Director
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC